You have no items in your shopping cart.
Cancer Highlights
In this section you will find Publication Series Analytical Tool Cancer Highlights market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities in the biotech, life science and pharmaceutical industries.
| Items 1 to 10 of 41 total | Page: | Show per page |
| View as: List Grid |
Sort by
|
Antibody Drug Target Atlas in Oncology - Where to Commercialize in a Crowded Market Place?
Published by BioSeeker Group on Mar 1st, 2010
€ 2,450.00
This report comprises defined and up to date development strategies for 441 antibody drugs (993 projects) within the portfolio of 168 investigators, from Ceased to Marketed. The report extensively analyses 225 identified targets of antibody drugs, organized into 234 drug target profiles, and assesses them in 69 different cancer indications. Learn More
Apoptotic Therapeutics in Oncology - Where To Commercialize?
Published by BioSeeker Group on Nov 30th, 2009
€ 2,450.00
The report is written for you to understand and assess the impact of competitor entry and corresponding changes to development strategies for your own portfolio products. It serves as an external commercial advocate for pharmaceutical companies’ portfolio planning and new product planning. Learn More
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published by BioSeeker Group on Oct 29th, 2009
€ 2,450.00
This report is an important part of creating and implementing a market development plan for any protein kinase drug in oncology to ensure that the optimal market conditions exist by the time the product is commercialized. Learn More
Competitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio Planning
Published by BioSeeker Group on Aug 25th, 2009
€ 2,450.00
This report is an important part of creating and implementing a market development plan for any lung cancer therapeutic drugs to ensure that the optimal market conditions exist by the time the product is commercialized. Learn More
Lymphoma Drug Development Strategies at Work - Define Your Competition
Published by BioSeeker Group on Jun 22nd, 2009
€ 1,950.00
This report will be an important part of creating and implementing a market development plan for any lymphoma therapeutic drug to ensure that the optimal market conditions exist by the time the product is commercialized. Learn More
Therapeutic Peptides in Oncology - Favorable Conditions But Where to Commercialize?
Published by BioSeeker Group on May 28th, 2009
€ 2,450.00
This report is an important part of creating and implementing a market development plan for any cancer therapeutic peptide drugs to ensure that the optimal market conditions exist by the time the product is commercialized. Learn More
Leukemia - A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking
Published by BioSeeker Group on Apr 3rd, 2009
€ 1,950.00
The report is written for you to understand and assess the impact of competitor entry and corresponding changes to development strategies for your own portfolio of leukemia products. Learn More
Currently Druggable in Colorectal Cancer: A Drug Target Competitive Analysis
Published by BioSeeker Group on Dec 19th, 2008
€ 1,950.00
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of colorectal cancer drugs. Learn More
Currently Druggable in Melanoma: A Drug Target Competitive Analysis
Published by BioSeeker Group on Oct 14th, 2008
€ 1,950.00
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of melanoma drugs. Learn More
Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis
Published by BioSeeker Group on Sep 8th, 2008
€ 1,950.00
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of prostate cancer drugs. Learn More
| Items 1 to 10 of 41 total | Page: | Show per page |
| View as: List Grid |
Sort by
|